InvestorsHub Logo

cabel

04/03/14 8:49 AM

#57945 RE: mdphd2008 #57944

It could have been a secondary thing to look for similar to how the Kevetrin trial was structured.

At the least let the PofC trial in Europe go ahead,.. for $100,000 it would pay for itself many times over.